What is Revolution Medicines, Inc. Common Stock's Market Cap?

Revolution Medicines, Inc. Common Stock's Market Cap is $44.4B, based on as-reported figures from SEC (XBRL) filings.

What is Revolution Medicines, Inc. Common Stock's Enterprise Value?

Revolution Medicines, Inc. Common Stock's Enterprise Value is $40.5B, based on as-reported figures from SEC (XBRL) filings.

What is Revolution Medicines, Inc. Common Stock's EV / EBITDA?

Revolution Medicines, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Revolution Medicines, Inc. Common Stock's Revenue (TTM)?

Revolution Medicines, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Revolution Medicines, Inc. Common Stock's Net Income (TTM)?

Revolution Medicines, Inc. Common Stock's Net Income (TTM) is -$1.8B, based on as-reported figures from SEC (XBRL) filings.

What is Revolution Medicines, Inc. Common Stock's EBITDA?

Revolution Medicines, Inc. Common Stock's EBITDA is -$1.6B, based on as-reported figures from SEC (XBRL) filings.

What is Revolution Medicines, Inc. Common Stock's Diluted EPS (TTM)?

Revolution Medicines, Inc. Common Stock's Diluted EPS (TTM) is -8.25, based on as-reported figures from SEC (XBRL) filings.

What is Revolution Medicines, Inc. Common Stock's Net Debt?

Revolution Medicines, Inc. Common Stock's Net Debt is -$3.9B, based on as-reported figures from SEC (XBRL) filings.

Revolution Medicines, Inc. Common Stock (RVMD) Financial Statements

Revolution Medicines, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00829F4Q7

XNAS · usd

207.32▼ 2.70 (-1.29%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close210.02

Day's Range206.30 – 213.00

52-Week Range39.73 – 224.31

Volume2.4M

Avg Volume1.7M

Share Statistics

Shares Outstanding

Employees883

ExchangeXNAS

Listed2020-02-13

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Revolution Medicines, Inc. Common Stock (RVMD)

What is Revolution Medicines, Inc. Common Stock's Market Cap?: Revolution Medicines, Inc. Common Stock's Market Cap is $44.4B, based on as-reported figures from SEC (XBRL) filings.
What is Revolution Medicines, Inc. Common Stock's Enterprise Value?: Revolution Medicines, Inc. Common Stock's Enterprise Value is $40.5B, based on as-reported figures from SEC (XBRL) filings.
What is Revolution Medicines, Inc. Common Stock's EV / EBITDA?: Revolution Medicines, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Revolution Medicines, Inc. Common Stock's Revenue (TTM)?: Revolution Medicines, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Revolution Medicines, Inc. Common Stock's Net Income (TTM)?: Revolution Medicines, Inc. Common Stock's Net Income (TTM) is -$1.8B, based on as-reported figures from SEC (XBRL) filings.
What is Revolution Medicines, Inc. Common Stock's EBITDA?: Revolution Medicines, Inc. Common Stock's EBITDA is -$1.6B, based on as-reported figures from SEC (XBRL) filings.
What is Revolution Medicines, Inc. Common Stock's Diluted EPS (TTM)?: Revolution Medicines, Inc. Common Stock's Diluted EPS (TTM) is -8.25, based on as-reported figures from SEC (XBRL) filings.
What is Revolution Medicines, Inc. Common Stock's Net Debt?: Revolution Medicines, Inc. Common Stock's Net Debt is -$3.9B, based on as-reported figures from SEC (XBRL) filings.